BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35265983)

  • 1. An Enhanced LC-MS-MS Technique for Distinguishing Δ8- and Δ9-Tetrahydrocannabinol Isomers in Blood and Urine Specimens.
    Reber JD; Karschner EL; Seither JZ; Knittel JL; Dozier KV; Walterscheid JP
    J Anal Toxicol; 2022 Apr; 46(4):343-349. PubMed ID: 35265983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated extraction and LC-MS-MS analysis of 11-nor-9-carboxy-tetrahydrocannabinol isomers and prevalence in authentic urine specimens.
    Karas LK; Patterson C; Fuller ZJ; Karschner EL
    J Anal Toxicol; 2024 May; 48(4):197-203. PubMed ID: 38581658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11-Nor-9-Carboxy-Δ8-Tetrahydrocannabinol, 7-Carboxy Cannabidiol, and 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol in Urine by LC-MS/MS.
    Hughs ML; McMillin GA
    Methods Mol Biol; 2024; 2737():161-174. PubMed ID: 38036820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of Δ8-THC, Δ9-THC, Cannabidiol and 10 Other Cannabinoids and Metabolites in Oral Fluid by HPLC-MS-MS.
    Lin L; Amaratunga P; Reed J; Huang P; Lemberg BL; Lemberg D
    J Anal Toxicol; 2022 Feb; 46(1):76-88. PubMed ID: 33270860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoids in Oral Fluid: Limiting Potential Sources of Cannabidiol Conversion to Δ9- and Δ8-Tetrahydrocannabinol.
    Coulter C; Wagner JR
    J Anal Toxicol; 2021 Sep; 45(8):807-812. PubMed ID: 34137890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS/MS quantification of Δ8-THC, Δ9-THC, THCV ISOMERS and their main metabolites in human plasma.
    Sempio C; Jorge Campos-Palomino MS; Klawitter J; Amy Harrison MA; Peters EN; MacNair L; Haghdoost M; Bonn-Miller M; Babalonis S; Huestis MA; Christians U; Klawitter J
    J Anal Toxicol; 2024 Jun; ():. PubMed ID: 38836589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of six cannabinoids and metabolites in oral fluid by liquid chromatography-tandem mass spectrometry.
    Desrosiers NA; Scheidweiler KB; Huestis MA
    Drug Test Anal; 2015 Aug; 7(8):684-94. PubMed ID: 25428610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a liquid chromatography tandem mass spectrometry (LC-MS/MS) method to detect cannabinoids in whole blood and breath.
    Hubbard JA; Smith BE; Sobolesky PM; Kim S; Hoffman MA; Stone J; Huestis MA; Grelotti DJ; Grant I; Marcotte TD; Fitzgerald RL
    Clin Chem Lab Med; 2020 Apr; 58(5):673-681. PubMed ID: 31527291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a Delta-9-Tetrahydrocannabinol Carboxylic Acid (Δ9-THC-COOH) Immunoassay and a Gas Chromatography-Mass Spectrometry (GC-MS) Method for the Detection of Delta-8-Tetrahydrocannabinol Carboxylic Acid (Δ8-THC-COOH).
    Baird SN; Frazee CC; Garg U
    J Appl Lab Med; 2023 Jul; 8(4):665-673. PubMed ID: 37071885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive determination of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol and complementary cannabinoids in hair using alkaline digestion and mixed-mode solid phase extraction followed by liquid-chromatography-tandem mass spectrometry.
    Schaefer VD; Müller VV; Feltraco Lizot LL; Hahn RZ; Schneider A; Antunes MV; Linden R
    Forensic Sci Int; 2021 Nov; 328():111047. PubMed ID: 34649099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of urinary metabolites of cannabidiol, Δ
    Sim YE; Kim JW; Ko BJ; Kim JY; Cheong JC; Pyo J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jan; 1214():123568. PubMed ID: 36527808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and quantification of cannabinoids in postmortem fluids and tissues by liquid chromatography-tandem mass spectrometry.
    Cliburn KD; Huestis MA; Wagner JR; Kemp PM
    J Chromatogr A; 2021 Aug; 1652():462345. PubMed ID: 34198104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent challenges and trends in forensic analysis: Δ9-THC isomers pharmacology, toxicology and analysis.
    La Maida N; Di Giorgi A; Pichini S; Busardò FP; Huestis MA
    J Pharm Biomed Anal; 2022 Oct; 220():114987. PubMed ID: 35985136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
    Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
    Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On-line SPE LC-MS/MS for the quantification of Δ9-tetrahydrocannabinol (THC) and its two major metabolites in human peripheral blood by liquid chromatography tandem mass spectrometry.
    König S; Aebi B; Lanz S; Gasser M; Weinmann W
    Anal Bioanal Chem; 2011 Apr; 400(1):9-16. PubMed ID: 21311875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous quantification of 11 cannabinoids and metabolites in human urine by liquid chromatography tandem mass spectrometry using WAX-S tips.
    Andersson M; Scheidweiler KB; Sempio C; Barnes AJ; Huestis MA
    Anal Bioanal Chem; 2016 Sep; 408(23):6461-71. PubMed ID: 27422645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and Urine Quantification of Delta-8 and Delta-9 Tetrahydrocannabinol Carboxylic Acid Using Gas Chromatography-Mass Spectrometry.
    Shell S; Clinton Frazee C; Garg U
    Methods Mol Biol; 2024; 2737():153-159. PubMed ID: 38036819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A crowdsourcing survey study on the subjective effects of delta-8-tetrahydrocannabinol relative to delta-9-tetrahydrocannabinol and cannabidiol.
    Bergeria CL; Strickland JC; Spindle TR; Kalaba M; Satyavolu PU; Feldner M; Vandrey R; Bonn-Miller M; Peters EN; Weerts E
    Exp Clin Psychopharmacol; 2023 Apr; 31(2):312-317. PubMed ID: 35467921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a Liquid Chromatography High-Resolution Mass Spectrometry (LC-HRMS) Bioanalytical Method for Quantifying Cannabinoids in Whole Blood: Application for Determining Recent Cannabis Use.
    DeGregorio MW; Audino SA; Montoya E; Phong A; Kao CJ; Wurz GT
    J AOAC Int; 2020 Jun; 103(3):725-735. PubMed ID: 33241370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.
    Sholler DJ; Spindle TR; Cone EJ; Goffi E; Kuntz D; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R
    J Anal Toxicol; 2022 May; 46(5):494-503. PubMed ID: 34089060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.